Stepan Company 2009 Annual Report (10-K) Summary
Business Context and Reporting Period
Company: Stepan Company (Stepan Co.)
Reporting Period: Fiscal year ended December 31, 2009
Business Overview: Stepan produces specialty and intermediate chemicals sold to manufacturers for end products in cleaning, personal care, construction, automotive, and food/pharmaceutical industries. The company operates three reportable segments: Surfactants (77% of 2009 sales), Polymers (20%), and Specialty Products (3%). Operations are global, with significant manufacturing in North America, Europe, and Latin America.
Key Financial Metrics (2009)
| Metric | 2009 Value | 2008 Value |
|---|---|---|
| Net Sales | $1,276.4 million | $1,600.1 million |
| Gross Profit | $233.1 million | $169.5 million |
| Operating Income | $104.9 million | $70.7 million |
| Net Income (Attributable to Stepan) | $63.0 million | $37.2 million |
| Diluted EPS | $5.84 | $3.52 |
| Cash Flow from Operations | $166.4 million | $29.1 million |
| Total Debt | $104.1 million | $143.0 million |
| Cash and Cash Equivalents | $98.5 million | $8.3 million |
| Working Capital | $186.3 million | $116.3 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 20% ($323.7 million) due to an 8% drop in sales volume (impacted by the global recession) and lower average selling prices driven by falling raw material costs. Foreign currency translation reduced sales by approximately $49.2 million.
- Profitability Surge: Despite lower sales, Net Income increased 70% to a record $63.0 million. This was driven by a 37% increase in Gross Profit ($63.6 million), as lower raw material and freight costs more than offset volume declines. Operating income rose 48% compared to 2008, which included one-time gains of $18.4 million from asset sales (polyurethane product lines and land).
- Balance Sheet Strengthening: The company significantly deleveraged. Total debt decreased by $38.9 million, while cash and cash equivalents increased by $90.3 million. Net debt (total debt minus cash) dropped from $126.3 million in 2008 to $5.6 million in 2009.
- Segment Performance:
- Surfactants: Sales down 19%, but operating income up 89% due to lower costs.
- Polymers: Sales down 27% (volume down 16% due to construction/automotive slowdown), operating income flat.
- Specialty Products: Sales up 3%, operating income up 112%.
Guidance, Outlook, and Risks
Outlook: Management expects a slow global economic recovery. The company is focused on organic growth and penetrating new end-use applications. Capital expenditures for 2010 are estimated between $65 million and $75 million, driven by capacity expansions in Germany and Brazil.
Key Risks and Contingencies:
- Raw Material Volatility: Costs for petroleum and plant-based raw materials, natural gas, and electricity are cyclical and volatile. The company may not always be able to pass cost increases to customers immediately.
- Environmental Liabilities: The company faces ongoing remediation costs at various sites (e.g., Maywood, NJ; Lightman Drum sites). Accrued liability for environmental and legal matters was $17.1 million at year-end, with a possible loss range of $7.8 million to $31.9 million.
- Foreign Currency: Approximately 37% of sales are outside the U.S. A strengthening U.S. dollar in 2009 negatively impacted reported sales and income.
- Deferred Compensation: Fluctuations in the company's stock price and mutual fund values significantly impact compensation expense. In 2009, this resulted in $7.0 million of expense.
Investor Verification Checklist
- Volume vs. Price Mix: Verify the sustainability of margin expansion given the 8% volume decline; assess if lower commodity prices are a temporary tailwind.
- Debt Covenants: Confirm continued compliance with debt covenants (interest coverage, net worth, leverage ratios) as the company maintains a $60 million revolving credit facility.
- Environmental Reserves: Monitor updates on the Maywood, NJ site and other Superfund liabilities, as actual remediation costs could exceed current estimates.
- Deferred Compensation Impact: Track the company's stock price volatility, as it directly influences administrative expenses and net income via the deferred compensation plan.
- Capital Expenditures: Review progress on the planned $65-$75 million in 2010 capex, specifically the expansions in Germany and Brazil, to ensure alignment with growth strategy.